Related references
Note: Only part of the references are listed.The interaction between SPARC and GRP78 interferes with ER stress signaling and potentiates apoptosis via PERK/eIF2α and IRE1α/XBP-1 in colorectal cancer
Yi-Jye Chern et al.
CELL DEATH & DISEASE (2019)
Multifaced Roles of the αvβ3 Integrin in Ehlers-Danlos and Arterial Tortuosity Syndromes' Dermal Fibroblasts
Nicoletta Zoppi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Application of Real-Time Cell Electronic Analysis System in Modern Pharmaceutical Evaluation and Analysis
Guojun Yan et al.
MOLECULES (2018)
αvβ3-or α5β1-Integrin-Selective Peptidomimetics for Surface Coating
Carlos Mas-Moruno et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Relationship between the Expression of the Extracellular Matrix Genes SPARC, SPP1, FN1, ITGA5 and ITGAV and Clinicopathological Parameters of Tumor Progression and Colorectal Cancer Dissemination
Luciano de Souza Viana et al.
ONCOLOGY (2013)
Exogenous SPARC Suppresses Proliferation and Migration of Prostate Cancer by Interacting With Integrin β1
Minkyoung Shin et al.
PROSTATE (2013)
Integrin β4 Regulates SPARC Protein to Promote Invasion
Kristin D. Gerson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
SPARC Is a Key Regulator of Proliferation, Apoptosis and Invasion in Human Ovarian Cancer
Jie Chen et al.
PLOS ONE (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
SPARC Promotes Cathepsin B-Mediated Melanoma Invasiveness through a Collagen I/α2β1 Integrin Axis
Maria R. Girotti et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival
N. Fenouille et al.
ONCOGENE (2011)
Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical Evaluation
Carlos Mas-Moruno et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2010)
Small Molecule Integrin Antagonists in Cancer Therapy
Mayra Paolillo et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2009)
Alternatively activated macrophages regulate extracellular levels of the hormone placental lactogen via receptor-mediated uptake and transcytosis
Julia Kzhyshkowska et al.
JOURNAL OF IMMUNOLOGY (2008)
Frequent inactivation of SPARC by promoter hypermethylation in colon cancers
Eungi Yang et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Secreted protein acidic and rich in cysteine (SPARC) inhibits integrin-mediated adhesion and growth factor-dependent survival signaling in ovarian cancer
Neveen Said et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
SPARC inhibits LPA-mediated mesothelial-ovarian cancer cell crosstalk
Neveen A. Said et al.
NEOPLASIA (2007)
Novel function of alternatively activated macrophages: Stabilin-1-mediated clearance of SPARC
Julia Kzhyshkowska et al.
JOURNAL OF IMMUNOLOGY (2006)
Integrins and angiogenesis: A sticky business
G Serini et al.
EXPERIMENTAL CELL RESEARCH (2006)
Integrins: Bidirectional, allosteric signaling machines
RO Hynes
CELL (2002)
αν-integrin antagonist EMD 121974 induces apoptosis in brain tumor cells growing on vitronectin and tenascin
T Taga et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury
AD Bradshaw et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Share Paper
